Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Fortuna Silver Mines Inc.

Start price
Target price
Perf. (%)
€3.61
12.12.22
-
12.12.23
0.72%
24.12.22

buy
Endeavour Silver Corp.

Start price
Target price
Perf. (%)
€3.12
12.12.22
-
12.12.23
0.40%
24.12.22

buy
flatexDEGIRO AG

Start price
Target price
Perf. (%)
€6.38
12.12.22
€10.00
08.12.23
-3.73%
14.12.22

EBIT growth > 30% per year expected
Known brand
Future proof or reliable business model
Higher EBIT margin than peer group
buy
B2gold Corp.

Start price
Target price
Perf. (%)
€3.19
12.12.22
€4.00
12.01.23
14.66%
13.01.23

Acer Therapeutics Inc

Start price
Target price
Perf. (%)
€2.85
12.12.22
-
12.12.23
-8.32%
24.12.22

buy
Agnico Eagle Mines Ltd

Start price
Target price
Perf. (%)
€48.67
12.12.22
€55.00
12.12.23
-4.84%
13.12.23

buy
Navya S.a.

Start price
Target price
Perf. (%)
€0.14
12.12.22
€0.20
12.12.23
-73.14%
22.12.22

Could be worthwhile Investment >10% per year
Spineway

Start price
Target price
Perf. (%)
€2.20
12.12.22
-
12.12.23
-61.36%
24.04.23

Risky Investment
Growths slower than the competition
buy
Box Inc. A

Start price
Target price
Perf. (%)
€28.70
12.12.22
€35.00
28.12.23
-25.02%
06.12.23

buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€15.36
12.12.22
-
12.12.23
-39.30%
24.12.22

buy
Adicet Bio Inc.

Start price
Target price
Perf. (%)
€10.20
12.12.22
-
12.12.23
-22.06%
24.12.22

Could be worthwhile Investment >10% per year
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.53
12.12.22
€5.00
12.12.23
-33.60%
12.12.22

buy
Affimed N.V.

Start price
Target price
Perf. (%)
€1.12
12.12.22
-
12.12.23
2.06%
24.12.22

buy
Eni SpA

Start price
Target price
Perf. (%)
€13.46
12.12.22
€15.00
12.12.23
1.52%
14.12.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
positive Cash Flow expected
buy
OMV AG

Start price
Target price
Perf. (%)
€46.70
12.12.22
€48.00
12.12.23
6.17%
24.12.22

Could be very worthwhile Investment >20% year
Fair valuation
Good rating
Standard Investments for future growth
buy
Royal Dutch Shell B

Start price
Target price
Perf. (%)
€22.55
12.12.22
€24.00
-
01.03.23

buy
Shell plc

Start price
Target price
Perf. (%)
€26.48
12.12.22
€27.00
12.12.23
4.61%
08.02.23

EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
negative Cash Flow expected
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€7.11
12.12.22
-
12.12.23
-63.02%
13.12.22

buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€512.50
12.12.22
-
12.12.23
-12.07%
06.03.23

HTG Molecular Diagnostics Inc.

Start price
Target price
Perf. (%)
€19.20
12.12.22
-
12.12.23
-57.00%
13.12.22

HTG Molecular Diagnostics Inc.

Start price
Target price
Perf. (%)
€19.20
12.12.22
€0.000
12.12.23
-63.50%
15.12.22

Capable Management
Risky Investment
No uniques
No Innovation
HTG Molecular Diagnostics Inc.

Start price
Target price
Perf. (%)
€13.03
12.12.22
-
12.12.23
-45.21%
02.04.23

buy
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.39
12.12.22
€7.00
12.12.23
-60.16%
24.12.22

Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Little innovation
CEWE Stiftung & Co KGaA

Start price
Target price
Perf. (%)
€90.60
12.12.22
-
12.12.23
7.51%
13.12.23

buy
Airbus Group SE

Start price
Target price
Perf. (%)
€114.08
12.12.22
-
12.01.23
-0.32%
12.12.22